Viatris

Viatris is a global pharmaceutical company, empowering people worldwide to live healthier at every stage of life. Viatris provides access to medicines, advances sustainable operations, develops innovative solutions and leverages collective expertise to connect more people to more products and services through their Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable diseases (NCDs) and infectious diseases, including globally recognized brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products.  Among NCDs, cancer is one of the leading causes of death worldwide, and the global cancer burden is increasing. Viatris is committed to playing its role in improving access and supporting the UICC global initiative to bridge the gap in cancer care and reduce the burden of cancer globally.